Search results
The German company BioNTech partnered with Pfizer to develop and test a coronavirus vaccine known as BNT162b2, the generic name tozinameran or the brand name Comirnaty.A clinical trial ...
The recommended interval between doses is eight weeks. Individuals, particularly those who are at risk for exposure to COVID-19 or severe disease, may receive the second dose earlier than eight weeks after the first dose but not less than 21 days for the Pfizer-BioNTech/Comirnaty and Novavax/Nuvaxovid vaccines, and 28 days for Moderna/Spikevax and Sinovac-CoronaVac vaccines.
Some people are only offered certain vaccines, for example, if you're under 18 years old. Children under 12 years old will be given smaller doses than older children and adults. Find out more about the COVID-19 vaccines used by the NHS: Spikevax (formerly Moderna) COVID-19 vaccine on GOV.UK; Pfizer/BioNTech (Comirnaty) COVID-19 vaccine on GOV.UK
At Pfizer, we believe that everyone should have the same opportunity to access the latest advances in cancer care, regardless of their background or where they live. That’s why we’re proud to partner with the American Cancer Society on “Change the Odds: Uniting to Improve Cancer Outcomes,” a three-year initiative to bridge the gap in ...
Jun 25, 2022 · Omicron-adapted monovalent candidate given as a fourth booster dose elicited a 13.5 and 19.6-fold increase in neutralizing geometric titers against Omicron BA.1 at 30 µg and 60 µg dose levels; bivalent vaccine candidate exhibited a 9.1 and 10.9-fold increase against Omicron Geometric mean ratios for Omicron neutralizing antibody response consistent with regulatory requirement of superiority ...
At Pfizer, we have a long history in vaccine research and development, including a pivotal role in the eradication of polio and smallpox. Through the development of innovative delivery systems and technologies (the term often used is “novel vaccines”), we’ve created innovations for preventing deadly bacterial infections like those caused ...
Apr 4, 2024 · Pfizer-BioNTech series: Children who received 1 or 2 doses of Pfizer-BioNTech vaccine for ages 6 months–4 years, 0.3 mL/3 ug (yellow cap; yellow label) are recommended to receive 1 dose of updated (2023–2024 Formula) Pfizer-BioNTech COVID-19 Vaccine, 0.3 mL/10 ug (blue cap; blue label) on or after turning age 5 years. If the 10 ug dose is ...
